$ZYNE News Article - Zynerba Pharmaceuticals Presents Positive Data from Phase 2 INSPIRE Trial in 22q at The Society for the Study of Behavioural Phenotypes (SSBP) 24th International Research Symposium
https://marketwirenews.com/news-releases/zyne...48335.html